CN114787198A - 具有生理活性的肽的制造方法以及包含短链接头的肽 - Google Patents

具有生理活性的肽的制造方法以及包含短链接头的肽 Download PDF

Info

Publication number
CN114787198A
CN114787198A CN202080084495.4A CN202080084495A CN114787198A CN 114787198 A CN114787198 A CN 114787198A CN 202080084495 A CN202080084495 A CN 202080084495A CN 114787198 A CN114787198 A CN 114787198A
Authority
CN
China
Prior art keywords
peptide
amino acid
pas
physiologically active
aet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080084495.4A
Other languages
English (en)
Chinese (zh)
Inventor
伊藤健一郎
松田吉彦
山田奈绪子
菊池庆实
小西敦
神崎道哉
高桥一敏
山口浩辉
藤原亚矢子
宫入匡平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of CN114787198A publication Critical patent/CN114787198A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN202080084495.4A 2019-12-06 2020-12-04 具有生理活性的肽的制造方法以及包含短链接头的肽 Pending CN114787198A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-221040 2019-12-06
JP2019221040 2019-12-06
PCT/JP2020/045327 WO2021112249A1 (ja) 2019-12-06 2020-12-04 生理活性を有するペプチドの製造方法及び短鎖リンカーを含むペプチド

Publications (1)

Publication Number Publication Date
CN114787198A true CN114787198A (zh) 2022-07-22

Family

ID=76221763

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080084495.4A Pending CN114787198A (zh) 2019-12-06 2020-12-04 具有生理活性的肽的制造方法以及包含短链接头的肽

Country Status (7)

Country Link
US (1) US20220396819A1 (https=)
EP (1) EP4071178A4 (https=)
JP (2) JPWO2021112249A1 (https=)
KR (1) KR20220110556A (https=)
CN (1) CN114787198A (https=)
AU (1) AU2020396647A1 (https=)
WO (1) WO2021112249A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240032941A (ko) 2021-07-07 2024-03-12 아지노모토 가부시키가이샤 비천연 아미노산 함유 단백질의 분비 생산법
JPWO2023200008A1 (https=) 2022-04-15 2023-10-19
WO2023234416A1 (ja) 2022-06-02 2023-12-07 味の素株式会社 親和性物質、化合物、抗体およびそれらの塩
EP4324843A1 (en) * 2022-08-18 2024-02-21 SenseUp GmbH Production of crm197
CN117024601A (zh) * 2023-07-14 2023-11-10 合肥工业大学 一种宣威火腿源抗氧化肽及其制备方法和活性测定方法
TW202602903A (zh) * 2024-03-18 2026-01-16 日商肽夢想股份有限公司 肽、肽複合物、醫藥組成物、細胞培養用組成物以及用於醫療用、診斷用或研究用的組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US6083913A (en) * 1995-06-07 2000-07-04 Glaxo Wellcome Inc. Peptides and compounds that bind to a thrombopoietin receptor
JP4035855B2 (ja) 1996-06-05 2008-01-23 味の素株式会社 Ｌ−リジンの製造法
JP2008519858A (ja) * 2004-11-11 2008-06-12 アフィーマックス・インコーポレイテッド エリスロポエチンレセプターに結合する新規ペプチド
EP1986677A2 (en) * 2006-01-25 2008-11-05 Amgen Inc. Thrombopoietic compounds
EP1975176A1 (en) * 2007-03-27 2008-10-01 Biocompatibles UK Limited Novel glp-1 fusion peptides, their production and use
JP2010083808A (ja) * 2008-09-30 2010-04-15 Institute Of Physical & Chemical Research 新規ペプチド誘導体を含む造血系細胞増殖促進剤
US9221882B2 (en) * 2010-05-21 2015-12-29 Technische Universitat Munchen Biosynthetic proline/alanine random coil polypeptides and their uses
JP2014534265A (ja) * 2011-11-28 2014-12-18 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド インスリンアミノ酸配列を含む治療薬
CN104684546A (zh) * 2012-06-07 2015-06-03 哈佛大学校长及研究员协会 用于药物靶向的纳米疗法
US9994616B2 (en) * 2013-10-15 2018-06-12 The University Of Tokyo c-Met protein agonist
DK3287523T3 (da) 2015-04-24 2022-07-25 Ajinomoto Kk Fremgangsmåde til sekretorisk fremstilling af protein
US11459397B2 (en) * 2016-01-08 2022-10-04 Meditope Biosciences Inc. Self-crosslinking antibodies
CN110891612A (zh) * 2017-06-21 2020-03-17 Xl-蛋白有限责任公司 蛋白质药物与p/a肽的缀合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GUO ET AL.: "Efficient soluble expression of two copies of EMP1 connected in series in Escherichia coli, with enhanced EPO activity", 《PROCESS BIOCHEMISTRY》, vol. 50, no. 5, 1 May 2015 (2015-05-01), pages 689 - 695, XP093159561, DOI: 10.1016/j.procbio.2015.02.002 *
JIANSONG YOU ET AL.: "Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb", 《APPL MICROBIOL BIOTECHNOL》, vol. 89, no. 6, 18 November 2010 (2010-11-18), pages 1885 - 1893, XP038162551, DOI: 10.1007/s00253-010-2991-7 *
KEI TOYAMA ET AL.: "Inhibition of EGFR Activation by Bivalent Ligands Based on a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR", 《CHEM PHARM BULL》, vol. 66, no. 11, 1 November 2018 (2018-11-01), pages 1083 - 1089, XP093159048, DOI: 10.1248/cpb.c18-00539 *

Also Published As

Publication number Publication date
AU2020396647A1 (en) 2022-07-07
JPWO2021112249A1 (https=) 2021-06-10
WO2021112249A1 (ja) 2021-06-10
EP4071178A4 (en) 2024-10-09
EP4071178A1 (en) 2022-10-12
US20220396819A1 (en) 2022-12-15
JP2025113367A (ja) 2025-08-01
KR20220110556A (ko) 2022-08-08

Similar Documents

Publication Publication Date Title
CN114787198A (zh) 具有生理活性的肽的制造方法以及包含短链接头的肽
CA2223833C (en) Compounds and peptides that bind to the erythropoietin receptor
JP4972191B2 (ja) ペプチド、蛋白質及びペプチドミメティック合成のための方法及び組成物
US20130136742A1 (en) Peptide having cell membrane penetrating activity
KR101972012B1 (ko) 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도
JP2011231085A (ja) 環状ペプチド
KR20100044128A (ko) 바이포달 펩타이드 바인더
WO2003091429A1 (en) Antimicrobial polypeptide and utizliation thereof
CN101668422A (zh) 用于促进药物活性剂在骨骼上定位的方法和组合物
WO2011071280A9 (ko) 세포내 타겟 결합용 바이포달 펩타이드 바인더
JP6017317B2 (ja) ペプチド・ライブラリー
KR20100093523A (ko) 세포투과성 ｒｕｎｘ３ 재조합 단백질, 이를 코딩하는 폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암 조성물
JP2001199997A (ja) 細胞透過性キャリアペプチド
US20090142855A1 (en) Polynucleotides and Polypeptides of the IL-12 Family of Cytokines
US11865181B2 (en) Peptidic materials that traffic efficiently to the cell cytosol and nucleus
JP5865002B2 (ja) 組換えプラスミドベクターおよびそれを用いたタンパク質の製造方法
US20240026343A1 (en) Method for screening dimerized cyclic peptide
CN112608366A (zh) 超正电荷聚多肽及其制备方法、应用
CN108440671B (zh) 一种来源于foxm1蛋白的抗肿瘤多肽
Beutel et al. Bind&Bite: Covalently stabilized heterodimeric coiled-coil peptides for the site-selective, cysteine-free chemical modification of proteins
CN102597771A (zh) 用于重定向抗体特异性的高亲和力衔接分子
WO2015115661A1 (ja) アゾール誘導体骨格を有するペプチドの製造方法
KR20210097547A (ko) 생체 물질 전달용 세포 투과성 펩타이드
CN112480262B (zh) 一种融合蛋白及其制备与应用
Stepurko Molecular insights into signalling mechanisms within TGF-β superfamily

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination